Not available
Quote | BioXcel Therapeutics Inc. (NASDAQ:BTAI)
Last: | $2.82 |
---|---|
Change Percent: | 0.0% |
Open: | $2.84 |
Close: | $2.82 |
High: | $2.905 |
Low: | $2.79 |
Volume: | 335,951 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | BioXcel Therapeutics Inc. (NASDAQ:BTAI)
2024-03-25 08:57:48 ET Read the full article on Seeking Alpha For further details see: BioXcel launches $25M direct offering of stock and warrants
2024-03-25 08:41:09 ET Read the full article on Seeking Alpha For further details see: Borr Drilling, Aehr Test Systems, Airship AI among premarket losers' pack
Message Board Posts | BioXcel Therapeutics Inc. (NASDAQ:BTAI)
Subject | By | Source | When |
---|---|---|---|
BioXcel Shares Drop Premarket Following Results for Phase | realfast95 | investorshub | 06/29/2023 12:02:20 PM |
$BTAI MomentumIts gaining | realfast95 | investorshub | 06/28/2023 3:11:47 PM |
Price gaining | Penny chatter | investorshub | 06/28/2023 6:01:26 AM |
$BTAI must see | realfast95 | investorshub | 06/25/2023 1:06:15 AM |
$BTAI Long and strong lets hope im right | realfast95 | investorshub | 06/24/2023 1:46:46 PM |
News, Short Squeeze, Breakout and More Instantly...
BioXcel Therapeutics Inc. Company Name:
BTAI Stock Symbol:
NASDAQ Market:
NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it h...
NEW HAVEN, Conn., March 15, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial ...
NEW HAVEN, Conn., March 15, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today reported that the European Patent Office (EPO) granted the C...